Sandoz Group AG

Sandoz Group AG

SDZNY

Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sandoz Group AGSandoz Group AG0----
$30.62

Current Fair Value

42.5% downside

Overvalued by 42.5% based on the discounted cash flow analysis.

Share Statistics

Market cap-
Enterprise Value-
Dividend Yield$- (-%)
Earnings per Share$-
Beta-
Outstanding Shares-

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Sandoz Group AG

22,049 employees
CEO: Mr. Richard Saynor

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides prot...